FULL PAPERS
(hold for 40 min), then rate 208CminÀ1 to 2308C and hold
for 20 min. Method B: b-Dex 225 column, 30ꢅ0.25 mm,
0.25 mm, T=1408C (hold for 60 min), then rate 208CminÀ1
to 2308C and hold for 5 min.
(R)-3-(2,5-Dioxopyrrolidin-1-yl)octanal (4f): 1H NMR
(400 MHz, chloroform-d): d=9.69 (t, J=1.3 Hz, 1H), 4.58
(tt, J=9.3, 5.5 Hz, 1H), 3.23 (ddd, J=17.9, 9.2, 1.6 Hz, 1H),
2.84 (ddd, J=17.9, 5.2, 1.0 Hz, 1H), 2.65 (s, 4H), 1.92 (dtd,
J=13.7, 9.6, 5.2 Hz, 1H), 1.62 (ddt, J=13.6, 10.9, 5.5 Hz,
1H), 1.31–1.11 (m, 6H), 0.88–0.81 (m, 3H); 13C NMR
(100 MHz, chloroform-d): d=199.56, 177.37, 46.63, 45.42,
31.63, 31.35, 28.04, 25.97, 22.55, 14.06. The ee was deter-
mined by GC analysis, Method B (R-isomer=104.9 min, S-
isomer=109.5 min). [a]2D5: +26.3 (c=0.5, CH2Cl2); HR-MS:
m/z=248.1245, calcd. for C12H19NNaO3: 248.1257 [M+
Na]+; FT-IR (neat): n=2930, 2860, 1772, 1694, 1396, 1369,
1176 cmÀ1.
(R)-3-(2,5-Dioxopyrrolidin-1-yl)butanal (4a): 1H NMR
(500 MHz, chloroform-d): d=9.69 (t, J=1.2 Hz, 1H), 4.76–
4.49 (m, 1H), 3.24 (ddd, J=18.1, 8.5, 1.4 Hz, 1H), 2.89 (ddd,
J=18.1, 5.9, 1.0 Hz, 1H), 2.65 (s, 4H), 1.38 (d, J=7.0 Hz,
3H); 13C NMR (125 MHz, chloroform-d): d=199.36, 177.15,
46.43, 42.14, 28.09, 18.02. The ee was determined by GC
analysis, Method
A
(R-isomer=30.1 min, S-isomer=
30.9 min); [a]2D5: +4.8 (c=0.5, CH2Cl2). The spectroscopic
data of this compound are consistent with the data available
in the literature.[29]
(R)-(Z)-3-(2,5-Dioxopyrrolidin-1-yl)non-6-enal
(4g):
1H NMR (500 MHz, chloroform-d): d=9.69 (t, J=1.3 Hz,
1H), 5.42–5.33 (m, 1H), 5.24 (dtt, J=10.4, 6.9, 1.6 Hz, 1H),
4.62 (tt, J=9.2, 5.4 Hz, 1H), 3.22 (ddd, J=17.9, 9.1, 1.7 Hz,
1H), 2.85 (ddd, J=17.9, 5.3, 1.0 Hz, 1H), 2.65 (s, 4H), 2.10–
1.93 (m, 5H), 1.75–1.66 (m, 1H), 0.93 (t, J=7.6 Hz, 3H);
13C NMR (125 MHz, chloroform-d): d=199.37, 177.32,
133.03, 127.21, 46.48, 45.45, 31.54, 28.05, 24.11, 20.68, 14.34.
The ee was determined by GC analysis, Method B (R-
isomer=165.9 min, S-isomer=173.9 min). [a]2D5: +27.3 (c=
0.5, CH2Cl2). The spectroscopic data of this compound are
consistent with the data available in the literature.[29]
(R)-3-(2,5-Dioxopyrrolidin-1-yl)pentanal (4b): 1H NMR
(500 MHz, chloroform-d): d=9.70 (d, J=1.3 Hz, 1H), 4.55–
4.49 (m, 1H), 3.25 (ddt, J=17.9, 9.3, 1.2 Hz, 1H), 2.86 (ddd,
J=17.9, 5.2, 1.0 Hz, 1H), 2.67 (s, 4H), 1.93 (ddt, J=14.6,
9.1, 7.2 Hz, 1H), 1.76–1.66 (m, 1H), 0.85 (t, J=7.4 Hz, 3H);
13C NMR (125 MHz, chloroform-d): d=199.56, 177.43,
48.04, 45.12, 28.01, 24.84, 10.79. The ee was determined by
GC analysis, Method B (R-isomer=35.5 min, S-isomer=
39.5 min). [a]2D5: +17.5 (c=0.5, CH2Cl2). The spectroscopic
data of this compound are consistent with the data available
in the literature.[29]
(R)-5-[(tert-Butyldimethylsilyl)oxy]-3-(2,5-dioxopyrroli-
din-1-yl)pentanal (4h): 1H NMR (500 MHz, chloroform-d):
d=9.69 (dd, J=1.8, 1.2 Hz, 1H), 4.79 (tt, J=9.0, 5.6 Hz,
1H), 3.60 (qdd, J=10.7, 6.8, 4.9 Hz, 2H), 3.19 (ddd, J=17.7,
9.1, 1.8 Hz, 1H), 2.90 (ddd, J=17.7, 5.3, 1.1 Hz, 1H), 2.63 (s,
4H), 2.14 (dddd, J=13.9, 9.0, 6.5, 4.8 Hz, 1H), 1.89 (dddd,
J=14.1, 7.0, 5.8, 5.0 Hz, 1H), 0.87 (s, 9H), 0.01 (s, 6H);
13C NMR (125 MHz, chloroform-d): d=199.56, 177.22,
60.35, 45.50, 44.45, 34.41, 28.08, 26.00, 18.41, À5.33, À5.37.
The ee was determined by GC analysis, Method B (R-
isomer=105.6 min, S-isomer=107.7 min). [a]2D5: +19.0 (c=
0.5, CH2Cl2). The spectroscopic data of this compound are
consistent with the data available in the literature.[29]
(R)-3-(2,5-Dioxopyrrolidin-1-yl)hexanal (4c): 1H NMR
(500 MHz, chloroform-d): d=9.68 (t, J=1.3 Hz, 1H), 4.60
(tt, J=9.3, 5.5 Hz, 1H), 3.22 (ddd, J=18.0, 9.1, 1.6 Hz, 1H),
2.84 (ddd, J=18.0, 5.2, 1.1 Hz, 1H), 2.64 (s, 4H), 1.92 (dtd,
J=13.7, 9.5, 5.7 Hz, 1H), 1.59 (dddd, J=13.7, 9.8, 6.4,
5.6 Hz, 1H), 1.29–1.13 (m, 2H), 0.89 (t, J=7.3 Hz, 3H);
13C NMR (125 MHz, chloroform-d): d=199.55, 177.37,
46.33, 45.39, 33.73, 28.02, 19.53, 13.65. The ee was deter-
mined by GC analysis, Method B (R-isomer=44.2 min, S-
isomer=46.4 min). [a]D25: +17.5 (c=0.5, CH2Cl2). The spec-
troscopic data of this compound are consistent with the data
available in the literature.[29]
(S)-3-(2,5-Dioxopyrrolidin-1-yl)-4-methylpentanal
(4d):
(S)-3-(2,5-Dioxopyrrolidin-1-yl)-3-phenylpropanal
(4i):
1H NMR (500 MHz, chloroform-d): d=9.68 (dd, J=1.9,
0.9 Hz, 1H), 4.22 (td, J=10.2, 4.0 Hz, 1H), 3.33 (ddd, J=
17.8, 10.5, 1.9 Hz, 1H), 2.83 (ddd, J=17.8, 4.0, 0.9 Hz, 1H),
2.65 (s, 4H), 2.27 (dp, J=9.7, 6.7 Hz, 1H), 0.96 (d, J=
6.7 Hz, 3H), 0.80 (d, J=6.7 Hz, 3H); 13C NMR (125 MHz,
chloroform-d): d=199.88, 177.51, 52.63, 43.09, 29.60, 27.95,
19.98, 19.58. The ee was determined by GC analysis, Method
B (R-isomer=190.8 min, S-isomer=200.5 min). [a]2D5: +15.5
(c=0.5, CH2Cl2); HR-MS: m/z=220.0940, calcd. for
C10H15NNaO3: 220.0944 [M+Na]+; FT-IR (neat): n=2966,
2876, 1771, 1692, 1390, 1369, 1182 cmÀ1.
1H NMR (500 MHz, chloroform-d): d=9.74 (t, J=0.8 Hz,
1H), 7.48–7.45 (m, 2H), 7.35–7.27 (m, 4H), 5.72 (dd, J=9.9,
5.5 Hz, 1H), 3.93 (ddd, J=18.5, 9.9, 1.1 Hz, 1H), 3.26 (ddd,
J=18.6, 5.5, 0.7 Hz, 1H), 2.64 (s, 4H); 13C NMR (125 MHz,
chloroform-d): d=198.81, 177.15, 138.12, 128.93, 128.53,
128.03, 49.69, 44.42, 28.10. The ee was determined by UPC2,
using an IC column with CO2/i-PrOH=90:10, P=1500 psi,
flow=3 mLminÀ1 (R-isomer=2.4 min, S-isomer=2.6 min).
[a]2D5: À5.1 (c=0.5, CH2Cl2); HR-MS: m/z=254.0784, calcd.
for C13H13NNaO3: 254.0788 [M+Na]+; FT-IR (neat): n=
3402, 1772, 1694, 1391, 1363, 1173 cmÀ1.
(R)-3-(2,5-Dioxopyrrolidin-1-yl)-5-methylhexanal
(4e):
(R)-3-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)butanal (4j):
1H NMR (500 MHz, chloroform-d): d=9.70 (t, J=1.2 Hz,
1H), 6.64 (s, 2H), 4.78–4.61 (m, 1H), 3.18 (ddd, J=17.9, 8.4,
1.4 Hz, 1H), 2.89 (ddd, J=18.0, 6.1, 1.1 Hz, 1H), 1.39 (d, J=
6.9 Hz, 3H); 13C NMR (125 MHz, chloroform-d): d=199.26,
170.57, 134.16, 47.36, 41.41, 19.00. The ee was determined by
GC analysis, Method B (R-isomer=12.7 min, S-isomer=
13.3 min). [a]2D5: +12.6 (c=0.5, CH2Cl2); HR-MS: m/z=
190.0475, calcd. for C8H9NNaO3: 190.0475 [M+Na]+; FT-IR
(neat): n=3102, 2941, 1696, 1404, 1367, 1173, 829, 694 cmÀ1.
(R)-3-(1,3-Dioxoisoindolin-2-yl)butanal (4k): 1H NMR
(500 MHz, chloroform-d): d=9.75 (t, J=1.3 Hz, 1H), 7.82
1H NMR (500 MHz, chloroform-d): d=9.67 (t, J=1.4 Hz,
1H), 4.68 (ddt, J=10.0, 9.0, 5.0 Hz, 1H), 3.19 (ddd, J=17.8,
9.1, 1.7 Hz, 1H), 2.80 (ddd, J=17.8, 5.3, 1.1 Hz, 1H), 2.64 (s,
4H), 2.01–1.90 (m, 1H), 1.42–1.33 (m, 2H), 0.91 (d, J=
6.1 Hz, 3H), 0.87 (d, J=6.3 Hz, 3H); 13C NMR (125 MHz,
chloroform-d): d=199.56, 177.34, 45.69, 44.78, 40.46, 28.04,
25.12, 23.00, 21.93. The ee was determined by GC analysis,
Method B (R-isomer=46.4 min, S-isomer=47.9 min). [a]2D5:
+30.0 (c=0.5, CH2Cl2); HR-MS: m/z=234.1102, calcd. for
C11H17NNaO3: 234.1101 [M+Na]+; FT-IR (neat): n=2961,
2872, 1770, 1689, 1367, 1176 cmÀ1.
Adv. Synth. Catal. 0000, 000, 0 – 0
9
ꢃ 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
ÞÞ
These are not the final page numbers!